The pathway changes in different places
Diagnostics, AI, therapies, and devices create value at different moments in care.
Use cases
Every innovation changes the pathway differently.
Medip frames value around the moment where your product changes care: a test result, algorithm output, treatment choice, or device implementation.
Diagnostics
Assess downstream pathway changes that start with a diagnostic decision.
AI in healthcare
Understand how performance, workflow fit, and implementation shape the real impact of AI.
Pharma and medtech
Translate complex therapeutic or device value into clearer local clinical and economic assessment.
Sector pages
Start with where value appears.
Each page focuses on the pathway change, stakeholder pressure, and evidence standard for one product type.
Diagnostics
Show how tests influence downstream care, patient selection, capacity, and economic consequences.
Explore diagnostics
Artificial intelligence
Assess AI in the context of clinical workflows, implementation constraints, and real-world variation.
Explore AI
Pharma
Connect treatment outcomes, long-term value, reimbursement evidence, and local affordability.
Explore pharma
Medtech
Understand how devices and procedures affect outcomes, capacity, staffing, and implementation.
Explore medtech
What changes
Same modelling discipline. Different value logic.
The method stays rigorous, but the emphasis shifts with the product, comparator, pathway, and decision setting.
The decision-maker changes
Some cases are driven by workflow, others by reimbursement, patient impact, or policy relevance.
The impact mix changes too
The core question may be downstream care, capacity relief, affordability, or broader system value.
Join the discussion
Discuss which use case best matches your innovation
We can help you identify the shortest route from product logic to a credible value story.
